ZEVRA THERAPEUTICS, INC. (ZVRA)

Latest Insider Confidence Score

2026Q1

45.2
Bearish

Company insider confidence (by quarter)

2015Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Bluhm Andrew G 10% Owner 4,095,914 Oct 9, 2018
Delaware Street Capital Master Fund, L.P. 10% Owner 4,095,914 Oct 9, 2018
DSC Advisors, L.P. 10% Owner 4,095,914 Oct 9, 2018
DSC Managers, L.L.C. 10% Owner 4,095,914 Oct 9, 2018
DSC Advisors, L.L.C. 10% Owner 4,095,914 Oct 9, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 7, 2026 Feb 10, 2026 McFarlane Neil F. CEO Sell 38.8 -14,625 -3.64% ✓ $125.2K
Feb 3, 2026 Feb 4, 2026 Sangiovanni Timothy J. SVP, Finance & Corp Controller Sell 31.9 -3,000 -9.21% ✓ $27.5K
Feb 3, 2026 Feb 4, 2026 Schafer Joshua CCO Sell 26.3 -10,500 -14.43% ✓ $96.5K
Jan 30, 2026 Feb 2, 2026 Sangiovanni Timothy J. SVP, Finance & Corp Controller Sell 31.9 -1,750 -7.72% ✓ $15.4K
Jan 30, 2026 Feb 2, 2026 Thompson Rahsaan Chief Legal & Compliance Sell 31.9 -4,080 -7.56% ✓ $36K
Jan 30, 2026 Feb 2, 2026 Quartel Adrian W Chief Medical Officer Sell 13.1 -4,533 -31.80% ✓ $40K
Jan 30, 2026 Feb 2, 2026 Schafer Joshua CCO Sell 31.9 -3,375 -8.27% ✓ $29.8K
Jan 31, 2026 Feb 2, 2026 McFarlane Neil F. CEO Sell 20.0 -91,000 -19.98% ✓ $853.4K
Dec 31, 2025 Jan 7, 2026 Clifton R. LaDuane Other Sell 40.0 -48,513 -25.26% ✗ $434.7K
Dec 2, 2025 Dec 9, 2025 Secor Alicia Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2025 Secor Alicia Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2025 Oct 10, 2025 McFarlane Neil F. CEO Sell 28.8 -19,500 -8.07% ✓ $210.9K
Sep 12, 2025 Sep 16, 2025 FAVORITO TAMARA A Director Buy 91.3 +3,175 441.59% ✗ $24.7K
Sep 12, 2025 Sep 15, 2025 Shih Alvin Director Buy 95.0 +20,000 100.00% ✗ $157.8K
Aug 19, 2025 Aug 20, 2025 Bode John B Director Buy 91.3 +5,000 12.50% ✗ $45.8K
Jun 26, 2025 Jun 30, 2025 Thompson Rahsaan Chief Legal & Compliance Sell 10.0 -24,000 -36.00% ✓ $221K
Jun 21, 2025 Jun 24, 2025 Thompson Rahsaan Chief Legal & Compliance Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Shih Alvin Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 DIXON WENDY L Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Calder Douglas W Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 FAVORITO TAMARA A Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Watton Corey Michael Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Bode John B Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Anderson Thomas Director Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Mar 31, 2025 Watton Corey Michael Director Buy 90.0 +300 20.00% ✗ $2.4K
Jan 30, 2025 Mar 27, 2025 Quartel Adrian W Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 27, 2025 Quartel Adrian W Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 19, 2025 Mar 21, 2025 Bode John B Director Buy 95.0 +10,000 33.33% ✗ $79.6K
Feb 13, 2025 Feb 14, 2025 Sangiovanni Timothy J. SVP, Finance & Corp Controller Sell 23.8 -3,000 -15.51% ✓ $23.6K
Feb 13, 2025 Feb 14, 2025 Schafer Joshua CCO & EVP, Bus. Development Sell 10.0 -10,500 -26.26% ✓ $82.5K
Feb 13, 2025 Feb 14, 2025 Clifton R. LaDuane CFO Sell 20.0 -11,000 -17.64% ✓ $86.5K
Feb 13, 2025 Feb 14, 2025 McFarlane Neil F. CEO Sell 7.5 -91,817 -32.41% ✓ $727.4K
Feb 7, 2025 Feb 10, 2025 McFarlane Neil F. CEO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 3, 2025 Sangiovanni Timothy J. SVP, Finance & Corp Controller Neutral 52.5 - 0.00% ✗ -
Jan 30, 2025 Feb 3, 2025 Thompson Rahsaan Chief Legal & Compliance Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 3, 2025 Schafer Joshua CCO & EVP, Bus. Development Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 3, 2025 Clifton R. LaDuane CFO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 3, 2025 McFarlane Neil F. CEO Neutral 52.5 - 0.00% ✗ -
Oct 11, 2024 Oct 16, 2024 Watton Corey Michael Director Buy 90.0 +500 50.00% ✗ $4K
Jul 17, 2024 Jul 17, 2024 Clifton R. LaDuane CFO Buy 91.3 +2,000 12.14% ✗ $13.5K
Jul 16, 2024 Jul 16, 2024 Anderson Thomas Director Buy 95.0 +10,000 100.00% ✗ $68.1K
Jul 12, 2024 Jul 15, 2024 Bode John B Director Buy 95.0 +10,000 50.00% ✗ $58.7K
Jun 21, 2024 Jun 25, 2024 Thompson Rahsaan Chief Legal & Compliance Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Thompson Rahsaan Chief Legal & Compliance Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 Bode John B Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 DIXON WENDY L Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 FAVORITO TAMARA A Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 Calder Douglas W Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 Watton Corey Michael Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 Shih Alvin Director Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 15, 2024 Anderson Thomas Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Schafer Joshua CCO & EVP, Bus. Development Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Sangiovanni Timothy J. SVP, Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Mickle Christal M M Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Guenther Sven Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Clifton R. LaDuane CFO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 McFarlane Neil F. CEO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2024 Feb 2, 2024 Shih Alvin Director Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Shih Alvin Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2023 Oct 11, 2023 McFarlane Neil F. CEO Neutral 52.5 - 0.00% ✗ -
Oct 10, 2023 McFarlane Neil F. CEO Neutral 52.5 - 0.00% ✗ -
Sep 5, 2023 Sep 6, 2023 Schafer Joshua CCO & EVP, Bus. Development Buy 90.0 +500 16.67% ✗ $2.6K
Sep 6, 2023 Sep 6, 2023 Clifton R. LaDuane CFO Buy 85.0 +1,000 6.99% ✗ $5K
Sep 5, 2023 Sep 6, 2023 Bode John B Director Buy 95.0 +10,000 100.00% ✗ $51.3K
Sep 6, 2023 Sep 6, 2023 Anderson Thomas Director Buy 91.3 +10,000 100.00% ✗ $48.8K
Aug 7, 2023 Aug 25, 2023 Anderson Thomas Director Neutral 52.5 - 0.00% ✗ -
Aug 24, 2023 Anderson Thomas Director Neutral 52.5 - 0.00% ✗ -
May 19, 2023 Jun 30, 2023 Schafer Joshua CCO & EVP, Bus. Development Buy 90.0 +1,000 50.00% ✗ $5.4K
Jun 23, 2023 Jun 26, 2023 Watton Corey Michael Director Buy 90.0 +275 37.93% ✗ $1.6K
Jun 9, 2023 Jun 13, 2023 Watton Corey Michael Director Buy 90.0 +325 81.25% ✗ $1.8K
May 31, 2023 Jun 2, 2023 FAVORITO TAMARA A Director Neutral 52.5 - 0.00% ✗ -
May 30, 2023 May 31, 2023 Watton Corey Michael Director Buy 90.0 +400 100.00% ✗ $2K
May 18, 2023 May 19, 2023 Bode John B Director Buy 95.0 +10,000 100.00% ✗ $50.4K
May 18, 2023 May 18, 2023 Clifton R. LaDuane CFO Buy 91.3 +2,740 24.90% ✗ $13.6K
May 3, 2023 May 11, 2023 Calder Douglas W Director Neutral 52.5 - 0.00% ✗ -
May 11, 2023 Calder Douglas W Director Neutral 52.5 - 0.00% ✗ -
May 3, 2023 May 8, 2023 Watton Corey Michael Director Neutral 52.5 - 0.00% ✗ -
Apr 25, 2023 May 8, 2023 Saluri Joseph Director Neutral 52.5 - 0.00% ✗ -
Apr 25, 2023 May 8, 2023 Plooster Matthew R Director Neutral 52.5 - 0.00% ✗ -
Apr 25, 2023 May 8, 2023 FAVORITO TAMARA A Director Neutral 52.5 - 0.00% ✗ -
Apr 25, 2023 May 8, 2023 DIXON WENDY L Director Neutral 52.5 - 0.00% ✗ -
May 3, 2023 May 8, 2023 Bode John B Director Neutral 52.5 - 0.00% ✗ -
May 8, 2023 Watton Corey Michael Director Neutral 52.5 - 0.00% ✗ -
May 8, 2023 DIXON WENDY L Director Neutral 52.5 - 0.00% ✗ -
May 8, 2023 Bode John B Director Neutral 52.5 - 0.00% ✗ -
Mar 17, 2023 Mar 21, 2023 SEYMOUR TAMARA A Director Buy 90.0 +519 259.50% ✗ $2.5K
Mar 14, 2023 Mar 15, 2023 Schafer Joshua CCO & EVP, Bus. Development Buy 90.0 +2,000 100.00% ✗ $9.2K
Mar 9, 2023 Mar 13, 2023 Plooster Matthew R Director Buy 91.3 +11,000 145.33% ✗ $46.1K
Mar 10, 2023 Mar 13, 2023 Sangiovanni Timothy J. SVP, Corporate Controller Buy 90.0 +1,200 36.93% ✗ $5K
Mar 10, 2023 Mar 13, 2023 Clifton R. LaDuane CFO Buy 90.0 +1,725 18.59% ✗ $7.2K
Mar 9, 2023 Mar 13, 2023 Tierney David S Director Buy 91.3 +5,000 85.69% ✗ $20.7K
Mar 9, 2023 Mar 13, 2023 Pascoe Richard W CEO Buy 91.3 +10,000 50.07% ✗ $42K
Jan 13, 2023 Jan 13, 2023 Clifton R. LaDuane CFO Buy 85.0 +635 7.35% ✗ $3.7K
Jan 13, 2023 Jan 13, 2023 Pascoe Richard W CEO Buy 95.0 +9,500 90.71% ✗ $51.7K
Jan 9, 2023 Jan 11, 2023 Clifton R. LaDuane CFO Neutral 52.5 - 0.00% ✗ -
Jan 9, 2023 Jan 11, 2023 Mickle Christal M M Chief Product Dev. Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2023 Jan 11, 2023 Guenther Sven Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2023 Jan 11, 2023 Schafer Joshua CCO & EVP, Bus. Development Neutral 52.5 - 0.00% ✗ -
Jan 9, 2023 Jan 11, 2023 Pascoe Richard W CEO Neutral 52.5 - 0.00% ✗ -
Jan 9, 2023 Jan 11, 2023 Sangiovanni Timothy J. SVP, Corporate Controller Neutral 52.5 - 0.00% ✗ -